HIV-mediated γδ T cell depletion is specific for Vγ2+ cells expressing the Jγ1.2 segment

被引:37
作者
Enders, PJ
Yin, C
Martini, F
Evans, PS
Propp, N
Poccia, F
Pauza, CD
机构
[1] Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA
[2] Natl Inst Infect Dis, Clin Pathol Lab, I-00149 Rome, Italy
关键词
PRENYL PYROPHOSPHATE ANTIGENS; PERIPHERAL-BLOOD; HIV-1-INFECTED INDIVIDUALS; MYCOBACTERIAL ANTIGENS; PULMONARY TUBERCULOSIS; NONPEPTIDE ANTIGENS; ANTIVIRAL FACTORS; INFECTED PERSONS; RECOGNITION; LYMPHOCYTES;
D O I
10.1089/08892220360473934
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Circulating Vgamma2/Vdelta2(+) T cells, normally constituting 3-6% of all CD3(+) T cells in blood, are severely depleted after HIV infection. The mechanism(s) for Vgamma2/Vdelta2(+) T cell depletion are unknown, partly because these cells are CD4(-) and resistant to HIV infection. To determine whether this cell depletion was general for all Vgamma2(+) cells or specific for an individual subset, we analyzed the Vgamma2 repertoire and found consistent differences between HIV+ and uninfected control samples. The change in Vgamma2 repertoire was the result of preferentially depleting only those Vgamma2 cells that express the Jgamma1.2 segment. The specific loss of Vgamma2-Jgamma1.2(+) cells was polyclonal, as the Vgamma subset retained normal diversity even after HIV infection, and loss occurred without significant changes in the paired chain (Vdelta2) repertoire, or in the alternate Vdelta1 chain repertoire. Specific depletion of Vgamma2-Jgamma1.2/Vdelta2 T cells is the first evidence of a common, T cell receptor-dependent cell loss in HIV disease and it provides a clear example of bystander cell depletion. Vgamma2-Jgamma1.2/Vdelta2 T cells mediate potent responses to microbial pathogens including HIV, and loss of this subset is an important aspect of AIDS pathogenesis.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 38 条
  • [1] BOULLIER S, 1995, J IMMUNOL, V154, P1418
  • [2] 2 FORMS OF THE T-CELL RECEPTOR GAMMA-PROTEIN FOUND ON PERIPHERAL-BLOOD CYTOTOXIC T-LYMPHOCYTES
    BRENNER, MB
    MCLEAN, J
    SCHEFT, H
    RIBERDY, J
    ANG, SL
    SEIDMAN, JG
    DEVLIN, P
    KRANGEL, MS
    [J]. NATURE, 1987, 325 (6106) : 689 - 694
  • [3] BUKOWSKI JF, 1994, J IMMUNOL, V153, P5133
  • [4] Bukowski JF, 1998, J IMMUNOL, V161, P286
  • [5] BUKOWSKI JF, 1995, J IMMUNOL, V154, P998
  • [6] Functional inactivation in the whole population of human V gamma 9/V delta 2 T lymphocytes induced by a nonpeptidic antagonist
    Burk, MR
    Carena, I
    Donda, A
    Mariani, F
    Mori, L
    DeLibero, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) : 91 - 97
  • [7] MOLECULAR ANALYSIS OF HUMAN GAMMA-DELTA+ CLONES FROM THYMUS AND PERIPHERAL-BLOOD
    CASORATI, G
    DELIBERO, G
    LANZAVECCHIA, A
    MIGONE, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (05) : 1521 - 1535
  • [8] HIV infection induces changes in CD4(+) T-cell phenotype and depletions within the CD4(+) T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
    Connors, M
    Kovacs, JA
    Krevat, S
    GeaBanacloche, JC
    Sneller, MC
    Flanigan, M
    Metcalf, JA
    Walker, RE
    Falloon, J
    Baseler, M
    Stevens, R
    Feuerstein, I
    Masur, H
    Lane, HC
    [J]. NATURE MEDICINE, 1997, 3 (05) : 533 - 540
  • [9] DAVODEAU F, 1993, J IMMUNOL, V151, P1214
  • [10] PERIPHERAL SELECTION OF ANTIGEN RECEPTOR JUNCTIONAL FEATURES IN A MAJOR HUMAN-GAMMA-DELTA SUBSET
    DAVODEAU, F
    PEYRAT, MA
    HALLET, MM
    HOUDE, I
    VIE, H
    BONNEVILLE, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (04) : 804 - 808